12 All Exposed In Utero 64 Marshallese. (A)Tactudes some cases not surgically treated. aAaNae MO (C)gased on age lesa than ten prevalence. ~ (B)gaaed on prevalence in unexposed ~N 46 AN 251 7 16 2 All Ages orer ar —_ 30 129 T< 2 Coa Gm 2) - oo 10-18 >18 .079(C) Expected Nod s}ea(8) oo oun 80 8 54 19 86 167 Ucirik In Utero <10 10-18 >18 Ail Ages No. with Carcinoma Qam am NS oS ~ CV] 2 - 2 15 3 3 23 Nodules (4) 2 - <10 hl 19 1 1 3 19 vt 32 65 Total Number Sifo In Utero » <0 10-18 >18 All Ages Ronge Lap Ia Utero <10 , 10-18 >18 All Ages Age at Exposure 600 4000 1700 1300 2100 610 1100 410 670 130 490 220 170 280 290 1400 760 470 790 0.0087(¢) 0.061 0.075 0.15 0.070) 0.47 0.24 0.59 1.4 0.10(C) 0.70 0.38 0.89 2.1 Mean Adsorbed Dose, rade 0.026(C) 0.17 0.16 0.22 0.56 Cancers (©) Expected SUMMARY OF THYROID DATA TABLE IV-17 ow ADaon oe eooon + ‘ 18(18) 2016) 20(22) 23(-) 16(18) 23(21) 22(-) 22(22) ~(-) 25(21) -(-) 18(-) 19(-) -(-) 22(-) 15(16) 23(-) 13415) 17(22) 4713) (Cancer), yeare Mean Time at Risk Mean Nodule Risk, no. per 106 per vad per year Mean Cencer Risk, no. per 106 per rad per year